15. Curr Opin Virol. 2015 Feb;10:47-55. doi: 10.1016/j.coviro.2014.12.003. Epub 2015 Feb 17.Origin, evolution and innate immune control of simian foamy viruses in humans.Rua R(1), Gessain A(2).Author information: (1)Institut Pasteur, Unité d'Epidémiologie et Physiopathologie des VirusOncogènes, 28 Rue du Dr. Roux, 75015 Paris, France; Département de Virologie,Institut Pasteur, 25-28 rue du Dr Roux, 75724 Paris, Cedex 15, France; CNRS,UMR369, 28 Rue du Dr. Roux, F-75015 Paris, France; Université Paris Diderot,Cellule Pasteur, Paris, France. Electronic address: rejane.rua@nih.gov.(2)Institut Pasteur, Unité d'Epidémiologie et Physiopathologie des VirusOncogènes, 28 Rue du Dr. Roux, 75015 Paris, France; Département de Virologie,Institut Pasteur, 25-28 rue du Dr Roux, 75724 Paris, Cedex 15, France; CNRS,UMR369, 28 Rue du Dr. Roux, F-75015 Paris, France.Most viral pathogens that have emerged in humans have originated from variousanimal species. Emergence is a multistep process involving an initial spill-over of the infectious agent into single individuals and its subsequent dissemination into the human population. Similar to simian immunodeficiency viruses and simian T lymphotropic viruses, simian foamy viruses (SFV) are retroviruses that arewidespread among non-human primates and can be transmitted to humans, giving riseto a persistent infection, which seems to be controlled in the case of SFV. Inthis review, we present current data on the discovery, cross-speciestransmission, and molecular evolution of SFV in human populations initiallyinfected and thus at risk for zoonotic emergence.Copyright © 2014 Elsevier B.V. All rights reserved.DOI: 10.1016/j.coviro.2014.12.003 PMID: 25698621  [Indexed for MEDLINE]